MedPath

Impact of Rotavirus Vaccination on Hospital Pressures at a Large Paediatric Hospital in the UK: an Ecological Study

Completed
Conditions
Gastroenteritis
Interventions
Other: No intervention
Registration Number
NCT03271593
Lead Sponsor
GlaxoSmithKline
Brief Summary

The impact of rotavirus vaccination on the burden of disease has been well documented. However, the anticipated reduction in hospital pressures has yet to be described. This study will provide quantitative measures of hospital pressure prior to and post vaccine introduction, provide a template for future hospital pressures studies related to vaccine introduction and provide measures which could be used in an economic evaluation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1
Inclusion Criteria
  • All children aged ≤15 years being hospitalised (with overnight stay or day clinic) for whatever reason during the study period
Read More
Exclusion Criteria
  • None
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
All children admittedNo interventionAll children admitted to hospital
Primary Outcome Measures
NameTimeMethod
Change in bed day occupancy (BDO) ratesDuring the study observation period of 15 years (1st July 2000 - 30th June 2015)

BDO rate is measured as the number of bed days occupied divided by the total number of bed days available in a ward during a fixed time period. BDO rate will be measured in overall admissions, admissions for infectious disease only, admissions for gastro-enteritis only, admissions for rotavirus induced gastro-enteritis only

Change in rate of nosocomial infections (NOSO)During the study observation period of 15 years (1st July 2000 - 30th June 2015)

NOSO rate is measured as positive test from a test taken \>2 days after admission. NOSO rate will be measured in overall admissions, admissions for infectious disease only, admissions for gastro-enteritis only, admissions for rotavirus induced gastro-enteritis only

Change in number of rotavirus gastroenteritis (RVAG) tests takenDuring the study observation period of 15 years (1st July 2000 - 30th June 2015)

RVAG rate will be measured in overall admissions, admissions for infectious disease only, admissions for gastro-enteritis only, admissions for rotavirus induced gastro-enteritis only

Change in turnover (TO) ratesDuring the study observation period of 15 years (1st July 2000 - 30th June 2015)

TO rate is the change in average hospital duration measured as average number of days stay per admission. TO rate will be measured in overall admissions, admissions for infectious disease only, admissions for gastro-enteritis only, admissions for rotavirus induced gastro-enteritis only

Change in early unplanned readmission (UR) ratesDuring the study observation period of 15 years (1st July 2000 - 30th June 2015)

UR rate (within 7 days after discharge) is measured as the number of readmissions ≤7 days after discharge (x100) divided by the total number of discharges. UR rate will be measured in overall admissions, admissions for infectious disease only, admissions for gastro-enteritis only, admissions for rotavirus induced gastro-enteritis only

Change in number of positive test resultsDuring the study observation period of 15 years (1st July 2000 - 30th June 2015)

Number of positive RVAG test results will be measured in overall admissions, admissions for infectious disease only, admissions for gastro-enteritis only, admissions for rotavirus induced gastro-enteritis only

Change in rate of hospitalization in children less that 5 years oldDuring the study observation period of 15 years (1st July 2000 - 30th June 2015)

Change in rate of hospitalization (in children less that 5 years old) will be measured in overall admissions, admissions for infectious disease only, admissions for gastro-enteritis only, admissions for rotavirus induced gastro-enteritis only

Secondary Outcome Measures
NameTimeMethod
Development of a Quality of Care (QoC) scoreDuring the study observation period of 15 years (1st July 2000 - 30th June 2015)

To develop the QoC score, a baseline rate/score for each outcome measure out-of-season (June-December) will be developed pre-vaccine introduction (vaccine introduction: 30th July 2013). Each outcome measure in the pre-vaccine period and post-vaccine period in-peak-season (January to May) will be scaled against that score. An overall QoC-Score pre- and post-vaccine in peak season will be calculated by summing scores for each outcome measure

© Copyright 2025. All Rights Reserved by MedPath